Gross Profit: Revenues from operations less the associated costs.
Apellis Pharmaceuticals, Inc. (APLS) had Gross Profit of $901.55M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$1.00B |
|
$22.39M |
|
$102.24M |
|
|
Gross Profit |
$901.55M |
$948.36M |
|
$55.43M |
|
$-31.32M |
|
$24.11M |
|
$24.11M |
|
$22.39M |
|
$22.39M |
|
$22.39M |
|
$22.39M |
|
$55.43M |
|
$59.48M |
|
126.14M |
|
129.85M |
|
$0.18 |
|
$0.20 |
|
| Balance Sheet Financials | |
$1.01B |
|
$1.71M |
|
$60.42M |
|
$1.08B |
|
$323.60M |
|
$361.66M |
|
$381.51M |
|
$705.11M |
|
$370.15M |
|
$370.15M |
|
$370.15M |
|
126.62M |
|
| Cash Flow Statement Financials | |
$45.33M |
|
$-0.31M |
|
$8.88M |
|
$412.61M |
|
$467.76M |
|
$55.15M |
|
$104.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.14 |
|
-- |
|
-- |
|
0.49 |
|
1.23 |
|
89.81% |
|
5.52% |
|
5.52% |
|
5.93% |
|
2.40% |
|
2.23% |
|
$45.01M |
|
-- |
|
-- |
|
-- |
|
0.93 |
|
0.72 |
|
2.74 |
|
133.17 |
|
6.05% |
|
6.05% |
|
2.08% |
|
3.06% |
|
$2.92 |
|
$0.35 |
|
$0.35 |
|